At a glance
- Originator Boehringer Ingelheim Pharma KG
- Developer Boehringer Ingelheim Pharma KG; Kyowa Hakko
- Class Antiulcers; Benzoxepins; Cytoprotectives; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer